US health regulators have been asked by Johnson & Johnson to authorize its single-dose COVID-19 vaccine for emergency use. The vaccine has had a rate of 66 percent of preventing infections in its large global trials. The supply of COVID-19 vaccines in the United States could be boosted with the single dose vaccine and could help increase the rate of the vaccination process.
go not let johnson and johnson release more vaccines. we (the democrats) need to figure out how to line our coffers privately.